Completed
Bevacizumab and Erlotinib in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
NCT00055913
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +18 more
- Locations
-
- University of Chicago Chicago, Illinois, United States